Cotización First Horizon Pharmaceutical - FHRX

Herramientas de nivel profesional para inversores individuales.

Premium

Último Precio

Postura de Compra

Postura de Venta

Volume Operado de la Acción

0.00 Rango del Día 0.00

0.00 Rango de 52 semanas 0.00

Precio Anterior

Precio de Apertura

Hora

Última hora de negociación

Volumen promedio (3 m)

Volumen financiero

Precio Promedio Ponderado

First Horizon Pharmaceutical Corporation Stockholders Approve Name Change to Sciele Pharma, Inc.

Stockholders of First Horizon Pharmaceutical Corporation (NASDAQ:FHRX), voting today at the Company's 2006 Annual Meeting, approved the Company's name change to Sciele Pharma, Inc. The Company's...

First Horizon Receives FDA Orphan Drug Designation for Its Glycopyrrolate to Treat Chronic Drooling in Pediatric Patients

First Horizon Pharmaceutical Corporation (NASDAQ:FHRX) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for the Company's glycopyrrolate, which...

SkyePharma to Develop Improved Controlled Release Version of Sular for First Horizon

LONDON, May 22 /PRNewswire-FirstCall/ -- SkyePharma PLC (NASDAQ:SKYE) ( LSE: SKP) announces that it has entered into an agreement with First Horizon Pharmaceutical Corporation ("First Horizon...

First Horizon Pharmaceutical Corporation

First Horizon Pharmaceutical Corporation (NASDAQ: FHRX), a specialty pharmaceutical company, today announced that the chairman of its Board of Directors, Dr. John N. Kapoor, through an...

First Horizon Pharmaceutical Corporation Increases Adjusted Diluted Earnings Per Share (EPS) Guidance by $0.10 to $1.27-$1.32 f

First Horizon Pharmaceutical Corporation (NASDAQ:FHRX) today announced that the Company has increased its adjusted diluted earnings per share (a non-GAAP measure) guidance by $0.10 to $1.27...

First Horizon Pharmaceutical Corporation Announces Expiration of and Successful 100% Participation in Its Exchange Offer for It

Exchange Offer Reduced Number of Fully Diluted Shares by Approximately 6,772,000 ? First Horizon Pharmaceutical Corporation (Nasdaq:FHRX), a specialty pharmaceutical company, today announced...

First Horizon to Present at Deutsche Bank Securities 31st Annual Health Care Conference

First Horizon Pharmaceutical Corporation (Nasdaq:FHRX), a specialty pharmaceutical company, today announced that Patrick Fourteau, President and Chief Executive Officer, will make a presentation...

First Horizon Pharmaceutical Reports Revenue and EPS Growth for the First Quarter 2006

First Horizon Pharmaceutical Corporation (NASDAQ:FHRX): ? First Quarter 2006 Results Include: ? -- Revenues increased 62% to $66.5 million compared with $41.0 million in the first quarter of...

First Horizon Pharmaceutical Corporation Announces Extension and Modification of Its Exchange Offer for Its Outstanding 1.75% C

First Horizon Pharmaceutical Corporation (Nasdaq:FHRX), a specialty pharmaceutical company, today announced that it is extending its exchange offer in which it is offering to exchange New 1.75...

First Horizon Announces First-Quarter 2006 Earnings Release Date and Conference Call

First Horizon Pharmaceutical Corporation (NASDAQ:FHRX), a specialty pharmaceutical company, will release financial results for the first quarter ended March 31, 2006, after the market closes...

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

FHRX - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de First Horizon Pharmaceutical?

El precio actual de las acciones de First Horizon Pharmaceutical es US$ 0.00

¿Cuál es el rango de negociación de 1 año para el precio de las acciones de First Horizon Pharmaceutical?

First Horizon Pharmaceutical ha negociado en un rango de US$ 0.00 a US$ 0.00 durante el último año

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
MYSZMy Size Inc	US$ 4.2001 (211.12%)	121.03M
NVNINVNI Group Ltd	US$ 8.26 (209.36%)	78.06M
TPICTPI Composites Inc	US$ 2.45 (100.82%)	34M
ICGIntchains Group Ltd	US$ 8.77 (88.60%)	527.94k
HSDTHelius Medical Technologies Inc	US$ 0.884851 (84.34%)	121.95M
CYNCYNGN Inc	US$ 0.4603 (-71.41%)	27.5M
MTEMMolecular Templates Inc	US$ 0.1502 (-57.09%)	8.63M
PRFXPainReform Ltd	US$ 5.15 (-53.85%)	2.84M
GALTGalectin Therapeutics Inc	US$ 1.03 (-48.50%)	8.58M
BCABBioAtla Inc	US$ 0.6923 (-41.82%)	5.96M
EDBLEdible Garden AG Inc	US$ 0.24 (65.06%)	354.33M
NVDANVIDIA Corporation	US$ 134.70 (3.08%)	310.19M
APTOAptose Biosciences Inc	US$ 0.28 (64.51%)	306.25M
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0.606999 (6.49%)	293.22M
PLTRPalantir Technologies Inc	US$ 80.55 (8.54%)	281.23M